However, a combination of trefoil factor 3 with other biomarkers of intestinal injury and inflammation (e.g., I-FABP and either the liver-FABP or SAA) has been demonstrated to be an early predictor of NEC outcome (65, 66). The gene discussed is FABP2; the disease is necrotizing enterocolitis.